Psyence Group Inc.

Dried edible fungi; dried edible mushrooms; dried edible mushrooms; edible fungi oils not containing psilocybin or psilocin, fungal extracts for use as ingredients of nutritional supplements; fruit jellies not being confectionary; Anti-epileptic pharmaceutical preparations; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the relief of pain; preparations for the treatment of mental health disorders; pharmaceutical preparations and herbal supplements for enhancing mental health; pharmaceutical preparations, namely cognitive enhancers for the treatment of mental health disorders; herbal supplements, namely cognitive enhancers; dietary supplements for enhancing mental health, and for the treatment of mental health disorders; dietary and nutritional supplements for alleviating symptoms experienced in the palliative care setting, namely, nausea, anorexia, cachexia, severe intractable pain, severe depressed mood, and insomnia; plant-based supplements for aiding general health, well-being and cognitive function; Research and development in the fields of neurological conditions and their treatment and psychological conditions and their treatment; basic and clinical research in the fields of plant-based medicines and psychedelics; research and development in the field of holistic medicines, natural medicine, psychedelics and nootropics; research and development of treatments for mental health conditions; pharmaceutical research and development in the field of psilocybin; research and development in the field of psilocybin, holistic medicines, natural medicine, psychedelics and nootropics; research and development of psilocybin-based treatments for mental health conditions; scientific research in the nature of conducting clinical trials for others in the field of medicine and mental health; providing scientific research information in the field of psilocybin, psychoactive products, psychedelics and nootropics; Fresh edible fungi; fresh edible mushrooms; fresh mushrooms; unprocessed mushrooms